Onderneming Easton Pharmaceuticals Inc. Other OTC
Aandelen
EAPH
US2777741057
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30-06-15 |
Vince Demasi
COO | Chief Operating Officer | - | 20-06-18 |
Chief Tech/Sci/R&D Officer | - | 01-01-15 | |
John Guerra
SEC | Corporate Secretary | - | 31-12-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30-06-15 |
John Guerra
SEC | Corporate Secretary | - | 31-12-13 |
Vince Demasi
COO | Chief Operating Officer | - | 20-06-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 309 122 163 | 1 309 122 163 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
![Adres Easton Pharmaceuticals Inc.(EAPH)](https://cdn.zonebourse.com/static/address/6058586.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,45% | 123 mld. | |
+21,96% | 115 mld. | |
+23,73% | 25,85 mld. | |
-20,05% | 20,9 mld. | |
-16,28% | 16,77 mld. | |
-16,52% | 16,52 mld. | |
-44,35% | 15,56 mld. | |
+63,91% | 15,49 mld. | |
+2,52% | 13,45 mld. |